MX337161B - Process for the manufacture of a vaccine reagent of erythrocytes parasitized by babesia bovis or babesia bigemina. - Google Patents
Process for the manufacture of a vaccine reagent of erythrocytes parasitized by babesia bovis or babesia bigemina.Info
- Publication number
- MX337161B MX337161B MX2012000670A MX2012000670A MX337161B MX 337161 B MX337161 B MX 337161B MX 2012000670 A MX2012000670 A MX 2012000670A MX 2012000670 A MX2012000670 A MX 2012000670A MX 337161 B MX337161 B MX 337161B
- Authority
- MX
- Mexico
- Prior art keywords
- babesia
- vaccine
- reagent
- manufacture
- vaccine reagent
- Prior art date
Links
Abstract
Provided is a method for the manufacture of a live attenuated bivalent vaccine reagent of Babesia bovis and Babesia bigemina which increases in at least 300% the production of the vaccine reagent (parasitized erythrocytes), which reduces in a substantial manner the time required for producing the batch vaccine, also reducing in a 90% the volume of the vaccine reagent (parasitized erythrocytes) by vaccine dose, and optimising the storage space. Additionally, the present invention recovers the Babesia proteins from the supernatant, which are also used as immunogens against the babesiosis and as antigens for diagnosis tests. The vaccine reagent obtained by the present invention has been assessed in laboratory tests and field tests, showing safety and effectiveness in cattle.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2012000670A MX337161B (en) | 2012-01-13 | 2012-01-13 | Process for the manufacture of a vaccine reagent of erythrocytes parasitized by babesia bovis or babesia bigemina. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2012000670A MX337161B (en) | 2012-01-13 | 2012-01-13 | Process for the manufacture of a vaccine reagent of erythrocytes parasitized by babesia bovis or babesia bigemina. |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2012000670A MX2012000670A (en) | 2012-08-31 |
MX337161B true MX337161B (en) | 2016-02-12 |
Family
ID=47225245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012000670A MX337161B (en) | 2012-01-13 | 2012-01-13 | Process for the manufacture of a vaccine reagent of erythrocytes parasitized by babesia bovis or babesia bigemina. |
Country Status (1)
Country | Link |
---|---|
MX (1) | MX337161B (en) |
-
2012
- 2012-01-13 MX MX2012000670A patent/MX337161B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
MX2012000670A (en) | 2012-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201591131A1 (en) | DNA STRUCTURE ANTIBODY AND METHOD OF THEIR APPLICATION | |
MX2018007022A (en) | Methods for treatng huntington's disease. | |
MX2013001613A (en) | Methods and compositions for preventing a condition. | |
MY171038A (en) | Bispecific antigen binding molecules | |
EA201400625A1 (en) | ANTIBODIES AGAINST PD-L1 AND THEIR APPLICATION | |
MX2022008523A (en) | Glycan-interacting compounds and methods of use. | |
BR112015012933A2 (en) | bcma antigen binding proteins | |
MX2015000863A (en) | Anti-siglec-15 antibodies. | |
MX344673B (en) | Apparatus and method for isolating leukocytes and tumor cells by filtration. | |
BR112017010793A2 (en) | genetically modified nonhuman animal, mouse, methods for producing a genetically modified nonhuman animal and screening for drug candidates directed to an antigen of interest, and, mouse model. | |
MX2014009628A (en) | Cdim binding proteins and uses thereof. | |
MX359854B (en) | Anti-cxcr3 antibodies. | |
EA201591791A1 (en) | MAN PAC1 ANTIBODIES | |
PH12020550169A1 (en) | Isothiocyanate containing brassicaceae products and method of preparation thereof | |
NZ703597A (en) | Mutant fragments of ospa and methods and uses relating thereto | |
NZ717399A (en) | Antibodies against csf-1r | |
MX2022006304A (en) | Compositions and methods for inhibiting the biological activity of soluble biomolecules. | |
UA105073C2 (en) | Anti-fractalkine antibody, composition and method for treating inflammatory disorders | |
GB201017519D0 (en) | Vaccines | |
WO2010045573A3 (en) | Tumor vaccine | |
MX2022000242A (en) | Antibodies to ticagrelor and methods of use. | |
TR201910413T4 (en) | Methods for improving asthma symptoms using benralizumab. | |
BR112016006383A2 (en) | protein extraction method | |
NZ724772A (en) | Antibodies against hpa-1a | |
SG10201903424RA (en) | ANTI HUMAN Gas6 MONOCLONAL ANTIBODY |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |